United States Biotechnology & Medical Research

Novelion Therapeutics Inc (NVLNF)

Track

Track

Ticker: NVLNF Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
STONEPINE CAPITAL, L.P. Large shareholder
Transaction date
Purchase
Price
426.36
Quantity 38,424 -11.1%
Value US$2,716,053
STONEPINE CAPITAL, L.P. Large shareholder
Transaction date
Purchase
Price
50.33
Quantity 62,142 +40.0%
Value US$100,488
STONEPINE CAPITAL, L.P. Large shareholder
Transaction date
Purchase
Price
193.69
Quantity 90,213 +23.3%
Value US$4,937,356
STONEPINE CAPITAL, L.P. Large shareholder
Transaction date
Purchase
Price
0.70
Quantity 4,500 +0.1%
Value US$3,150
STONEPINE CAPITAL, L.P. Large shareholder
Transaction date
Purchase
Price
0.70
Quantity 40 +0.0%
Value US$28
STONEPINE CAPITAL, L.P. Large shareholder
Transaction date
Purchase
Price
0.70
Quantity 5,160 +0.1%
Value US$3,612
STONEPINE CAPITAL, L.P. Large shareholder
Transaction date
Purchase
Price
0.75
Quantity 89,845 +2.4%
Value US$67,033
STONEPINE CAPITAL, L.P. Large shareholder
Transaction date
Purchase
Price
0.65
Quantity 100,000 +2.7%
Value US$64,900
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
0.85
Quantity 100,000 -6.3%
Value US$85,140
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
0.85
Quantity 56,316 -3.4%
Value US$48,139
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
0.88
Quantity 14,800 -0.9%
Value US$13,028
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
0.91
Quantity 30,726 -1.8%
Value US$27,868
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
0.91
Quantity 28,745 -1.7%
Value US$26,037
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
0.91
Quantity 12,219 -0.7%
Value US$11,108
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
0.87
Quantity 109,900 -5.9%
Value US$95,833
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
0.91
Quantity 12,450 -0.7%
Value US$11,302
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
0.98
Quantity 83,245 -4.3%
Value US$81,447
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
0.93
Quantity 1,200 -0.1%
Value US$1,119
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
0.98
Quantity 400 -0.0%
Value US$392
Stern Donald K
Transaction date
Purchase
Price
9.10
Quantity 2,500 +inf%
Value US$22,750
Aryeh Jason Non-Executive Director
Transaction date
Purchase
Price
8.95
Quantity 361 +0.1%
Value US$3,231
STONEPINE CAPITAL, L.P. Large shareholder
Transaction date
Purchase
Price
1.55
Quantity 14,928 +0.3%
Value US$23,138
STONEPINE CAPITAL, L.P. Large shareholder
Transaction date
Purchase
Price
1.55
Quantity 56,864 +1.0%
Value US$88,270
STONEPINE CAPITAL, L.P. Large shareholder
Transaction date
Purchase
Price
1.54
Quantity 61,704 +1.1%
Value US$95,166
Aryeh Jason Non-Executive Director
Transaction date
Purchase
Price
2.49
Quantity 400 +0.1%
Value US$996
Aryeh Jason Non-Executive Director
Transaction date
Purchase
Price
2.50
Quantity 18,000 +4.1%
Value US$45,000
Aryeh Jason Non-Executive Director
Transaction date
Purchase
Price
3.47
Quantity 288,000 +inf%
Value US$999,360
AXIAL CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Sale
Price
3.47
Quantity 8,865,036 -100.0%
Value US$30,771,426
Axial Capital Master, L.P. Large shareholder
Transaction date
Sale
Price
3.47
Quantity 7,563,053 -100.0%
Value US$26,252,113
KOZARICH JOHN W Non-Executive Director
Transaction date
Purchase
Price
3.62
Quantity 900 +4.3%
Value US$3,258
KOZARICH JOHN W Non-Executive Director
Transaction date
Purchase
Price
3.62
Quantity 600 +2.9%
Value US$2,172
KOZARICH JOHN W Non-Executive Director
Transaction date
Purchase
Price
3.62
Quantity 4,400 +27.3%
Value US$15,928
KOZARICH JOHN W Non-Executive Director
Transaction date
Purchase
Price
3.62
Quantity 900 +5.9%
Value US$3,258
KOZARICH JOHN W Non-Executive Director
Transaction date
Purchase
Price
3.63
Quantity 600 +4.1%
Value US$2,178
KOZARICH JOHN W Non-Executive Director
Transaction date
Purchase
Price
3.63
Quantity 900 +6.6%
Value US$3,267
KOZARICH JOHN W Non-Executive Director
Transaction date
Purchase
Price
3.45
Quantity 1,700 +14.2%
Value US$5,865
Meckler Jeffrey A Non-Executive Director
Transaction date
Purchase
Price
3.60
Quantity 20,000 +38.5%
Value US$72,000
NB Public Equity K/S Large shareholder
Transaction date
Sale
Price
5.80
Quantity 1,000,000 -13.4%
Value US$5,800,000
Axial Capital Master, L.P. Large shareholder
Transaction date
Sale
Price
4.39
Quantity 288,890 -3.7%
Value US$1,268,227
Meckler Jeffrey A Non-Executive Director
Transaction date
Purchase
Price
4.36
Quantity 30,000 +150.0%
Value US$130,800
Jagpal Sukhi Chief Financial Officer Officer
Transaction date
Sale
Price
7.96
Quantity 100 -7.7%
Value US$796
Jagpal Sukhi Chief Financial Officer Officer
Transaction date
Sale
Price
7.95
Quantity 9,900 -88.4%
Value US$78,705
KOZARICH JOHN W Non-Executive Director
Transaction date
Purchase
Price
7.97
Quantity 10,000 +inf%
Value US$79,700
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Sale
Price
7.85
Quantity 90,000 -81.8%
Value US$706,500
Meckler Jeffrey A Non-Executive Director
Transaction date
Purchase
Price
7.96
Quantity 20,000 +inf%
Value US$159,200
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Sale
Price
7.51
Quantity 50,000 -71.4%
Value US$375,315
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Sale
Price
7.53
Quantity 180,000 -90.0%
Value US$1,354,734
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Planned sale
Price
8.02
Quantity 5,000 -20.0%
Value US$40,100
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Planned sale
Price
7.88
Quantity 5,000 -20.0%
Value US$39,400
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Planned sale
Price
7.81
Quantity 5,000 -20.0%
Value US$39,050
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Planned sale
Price
7.52
Quantity 5,000 -20.0%
Value US$37,600
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Planned sale
Price
7.72
Quantity 5,000 -20.0%
Value US$38,600
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Planned sale
Price
7.72
Quantity 5,000 -20.0%
Value US$38,600
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Planned sale
Price
7.57
Quantity 5,000 -20.0%
Value US$37,850
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Planned sale
Price
7.55
Quantity 5,000 -20.0%
Value US$37,750
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Planned sale
Price
7.67
Quantity 5,000 -20.0%
Value US$38,350
LUPINI LINDA Senior VP, HR & Org. Dev. Officer
Transaction date
Sale
Price
7.58
Quantity 77,007 -83.7%
Value US$583,929
LUPINI LINDA Senior VP, HR & Org. Dev. Officer
Transaction date
Sale
Price
7.85
Quantity 22,993 -60.5%
Value US$180,495
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Planned sale
Price
7.92
Quantity 5,000 -20.0%
Value US$39,600
Jagpal Sukhi Interim CFO Officer
Transaction date
Sale
Price
8.19
Quantity 67,000 -98.2%
Value US$548,730
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Planned sale
Price
8.28
Quantity 5,000 -20.0%
Value US$41,400
CLARKE C BOYD Former Director
Transaction date
Sale
Price
7.62
Quantity 20,000 -100.0%
Value US$152,460
CLARKE C BOYD Former Director
Transaction date
Sale
Price
7.62
Quantity 55,450 -100.0%
Value US$422,291
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Planned sale
Price
7.53
Quantity 5,000 -20.0%
Value US$37,650
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Planned sale
Price
7.65
Quantity 5,000 -20.0%
Value US$38,250
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Planned sale
Price
7.47
Quantity 5,000 -20.0%
Value US$37,350
NB Public Equity K/S Large shareholder
Transaction date
Purchase
Price
6.67
Quantity 50,000 +0.7%
Value US$333,340
CLARKE C BOYD Non-Executive Director
Transaction date
Purchase
Price
6.56
Quantity 2,450 +3.4%
Value US$16,072
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Sale
Price
6.73
Quantity 20,000 -50.0%
Value US$134,522
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Sale
Price
6.85
Quantity 4,400 -9.9%
Value US$30,120
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Sale
Price
7.03
Quantity 5,600 -21.9%
Value US$39,361
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Purchase
Price
6.78
Quantity 1,300 +7.0%
Value US$8,813
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Purchase
Price
6.77
Quantity 2,200 +13.3%
Value US$14,897
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Purchase
Price
6.76
Quantity 1,500 +10.0%
Value US$10,143
Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. Officer
Transaction date
Purchase
Price
6.96
Quantity 400 +2.7%
Value US$2,783
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-12-12 2019-12-12 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
38,424 -11.1%
426.36
US$2,716,053 		38,424 -11.1% 426.36 US$2,716,053
2019-12-12 2019-12-11 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
62,142 +40.0%
50.33
US$100,488 		62,142 +40.0% 50.33 US$100,488
2019-12-12 2019-12-10 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
90,213 +23.3%
193.69
US$4,937,356 		90,213 +23.3% 193.69 US$4,937,356
2019-12-09 2019-12-09 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
4,500 +0.1%
0.70
US$3,150 		4,500 +0.1% 0.70 US$3,150
2019-12-09 2019-12-06 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
40 +0.0%
0.70
US$28 		40 +0.0% 0.70 US$28
2019-12-09 2019-12-05 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
5,160 +0.1%
0.70
US$3,612 		5,160 +0.1% 0.70 US$3,612
2019-11-26 2019-11-22 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
89,845 +2.4%
0.75
US$67,033 		89,845 +2.4% 0.75 US$67,033
2019-10-16 2019-10-11 B Purchase
STONEPINE CAPITAL, L.P.
Large shareholder
100,000 +2.7%
0.65
US$64,900 		100,000 +2.7% 0.65 US$64,900
2018-12-27 2018-12-27 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
100,000 -6.3%
0.85
US$85,140 		100,000 -6.3% 0.85 US$85,140
2018-12-27 2018-12-27 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
56,316 -3.4%
0.85
US$48,139 		56,316 -3.4% 0.85 US$48,139
2018-12-27 2018-12-27 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
14,800 -0.9%
0.88
US$13,028 		14,800 -0.9% 0.88 US$13,028
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
30,726 -1.8%
0.91
US$27,868 		30,726 -1.8% 0.91 US$27,868
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
28,745 -1.7%
0.91
US$26,037 		28,745 -1.7% 0.91 US$26,037
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
12,219 -0.7%
0.91
US$11,108 		12,219 -0.7% 0.91 US$11,108
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
109,900 -5.9%
0.87
US$95,833 		109,900 -5.9% 0.87 US$95,833
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
12,450 -0.7%
0.91
US$11,302 		12,450 -0.7% 0.91 US$11,302
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
83,245 -4.3%
0.98
US$81,447 		83,245 -4.3% 0.98 US$81,447
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
1,200 -0.1%
0.93
US$1,119 		1,200 -0.1% 0.93 US$1,119
2018-12-27 2018-12-24 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
400 -0.0%
0.98
US$392 		400 -0.0% 0.98 US$392
2017-06-13 2017-06-12 B Purchase Stern Donald K
2,500 +inf%
9.10
US$22,750 		2,500 +inf% 9.10 US$22,750
2017-05-17 2017-05-15 B Purchase Aryeh Jason Non-Executive Director
361 +0.1%
8.95
US$3,231 		361 +0.1% 8.95 US$3,231
2016-09-15 2016-09-15 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
14,928 +0.3%
1.55
US$23,138 		14,928 +0.3% 1.55 US$23,138
2016-09-15 2016-09-14 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
56,864 +1.0%
1.55
US$88,270 		56,864 +1.0% 1.55 US$88,270
2016-09-15 2016-09-13 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
61,704 +1.1%
1.54
US$95,166 		61,704 +1.1% 1.54 US$95,166
2015-12-30 2015-12-29 B Purchase Aryeh Jason Non-Executive Director
400 +0.1%
2.49
US$996 		400 +0.1% 2.49 US$996
2015-12-30 2015-12-29 B Purchase Aryeh Jason Non-Executive Director
18,000 +4.1%
2.50
US$45,000 		18,000 +4.1% 2.50 US$45,000
2015-06-18 2015-06-16 B Purchase Aryeh Jason Non-Executive Director
288,000 +inf%
3.47
US$999,360 		288,000 +inf% 3.47 US$999,360
2015-06-17 2015-06-16 S Sale AXIAL CAPITAL MANAGEMENT, LLC Large shareholder
8,865,036 -100.0%
3.47
US$30,771,426 		8,865,036 -100.0% 3.47 US$30,771,426
2015-06-17 2015-06-16 S Sale Axial Capital Master, L.P. Large shareholder
7,563,053 -100.0%
3.47
US$26,252,113 		7,563,053 -100.0% 3.47 US$26,252,113
2014-12-23 2014-12-22 B Purchase KOZARICH JOHN W Non-Executive Director
900 +4.3%
3.62
US$3,258 		900 +4.3% 3.62 US$3,258
2014-12-23 2014-12-22 B Purchase KOZARICH JOHN W Non-Executive Director
600 +2.9%
3.62
US$2,172 		600 +2.9% 3.62 US$2,172
2014-12-23 2014-12-22 B Purchase KOZARICH JOHN W Non-Executive Director
4,400 +27.3%
3.62
US$15,928 		4,400 +27.3% 3.62 US$15,928
2014-12-23 2014-12-22 B Purchase KOZARICH JOHN W Non-Executive Director
900 +5.9%
3.62
US$3,258 		900 +5.9% 3.62 US$3,258
2014-12-23 2014-12-22 B Purchase KOZARICH JOHN W Non-Executive Director
600 +4.1%
3.63
US$2,178 		600 +4.1% 3.63 US$2,178
2014-12-23 2014-12-22 B Purchase KOZARICH JOHN W Non-Executive Director
900 +6.6%
3.63
US$3,267 		900 +6.6% 3.63 US$3,267
2014-12-23 2014-12-19 B Purchase KOZARICH JOHN W Non-Executive Director
1,700 +14.2%
3.45
US$5,865 		1,700 +14.2% 3.45 US$5,865
2014-12-19 2014-12-18 B Purchase Meckler Jeffrey A Non-Executive Director
20,000 +38.5%
3.60
US$72,000 		20,000 +38.5% 3.60 US$72,000
2014-07-15 2014-07-11 S Sale NB Public Equity K/S Large shareholder
1,000,000 -13.4%
5.80
US$5,800,000 		1,000,000 -13.4% 5.80 US$5,800,000
2013-07-02 2013-07-01 S Sale Axial Capital Master, L.P. Large shareholder
288,890 -3.7%
4.39
US$1,268,227 		288,890 -3.7% 4.39 US$1,268,227
2013-07-01 2013-06-28 B Purchase Meckler Jeffrey A Non-Executive Director
30,000 +150.0%
4.36
US$130,800 		30,000 +150.0% 4.36 US$130,800
2013-05-15 2013-05-14 S Sale Jagpal Sukhi

Chief Financial Officer

Officer
100 -7.7%
7.96
US$796 		100 -7.7% 7.96 US$796
2013-05-15 2013-05-14 S Sale Jagpal Sukhi

Chief Financial Officer

Officer
9,900 -88.4%
7.95
US$78,705 		9,900 -88.4% 7.95 US$78,705
2013-05-14 2013-05-13 B Purchase KOZARICH JOHN W Non-Executive Director
10,000 +inf%
7.97
US$79,700 		10,000 +inf% 7.97 US$79,700
2013-05-06 2013-05-03 S Sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
90,000 -81.8%
7.85
US$706,500 		90,000 -81.8% 7.85 US$706,500
2013-05-06 2013-05-03 B Purchase Meckler Jeffrey A Non-Executive Director
20,000 +inf%
7.96
US$159,200 		20,000 +inf% 7.96 US$159,200
2012-12-28 2012-12-28 S Sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
50,000 -71.4%
7.51
US$375,315 		50,000 -71.4% 7.51 US$375,315
2012-12-28 2012-12-27 S Sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
180,000 -90.0%
7.53
US$1,354,734 		180,000 -90.0% 7.53 US$1,354,734
2012-12-13 2012-12-12 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
8.02
US$40,100 		5,000 -20.0% 8.02 US$40,100
2012-11-29 2012-11-28 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.88
US$39,400 		5,000 -20.0% 7.88 US$39,400
2012-11-21 2012-11-20 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.81
US$39,050 		5,000 -20.0% 7.81 US$39,050
2012-11-05 2012-11-01 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.52
US$37,600 		5,000 -20.0% 7.52 US$37,600
2012-10-23 2012-10-22 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.72
US$38,600 		5,000 -20.0% 7.72 US$38,600
2012-10-05 2012-10-05 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.72
US$38,600 		5,000 -20.0% 7.72 US$38,600
2012-09-19 2012-09-18 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.57
US$37,850 		5,000 -20.0% 7.57 US$37,850
2012-09-06 2012-09-05 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.55
US$37,750 		5,000 -20.0% 7.55 US$37,750
2012-08-20 2012-08-20 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.67
US$38,350 		5,000 -20.0% 7.67 US$38,350
2012-08-15 2012-08-13 S Sale LUPINI LINDA

Senior VP, HR & Org. Dev.

Officer
77,007 -83.7%
7.58
US$583,929 		77,007 -83.7% 7.58 US$583,929
2012-08-10 2012-08-08 S Sale LUPINI LINDA

Senior VP, HR & Org. Dev.

Officer
22,993 -60.5%
7.85
US$180,495 		22,993 -60.5% 7.85 US$180,495
2012-08-08 2012-08-08 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.92
US$39,600 		5,000 -20.0% 7.92 US$39,600
2012-08-07 2012-08-03 S Sale Jagpal Sukhi

Interim CFO

Officer
67,000 -98.2%
8.19
US$548,730 		67,000 -98.2% 8.19 US$548,730
2012-07-25 2012-07-24 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
8.28
US$41,400 		5,000 -20.0% 8.28 US$41,400
2012-07-11 2012-07-09 S Sale CLARKE C BOYD

Former Director
20,000 -100.0%
7.62
US$152,460 		20,000 -100.0% 7.62 US$152,460
2012-07-11 2012-07-09 S Sale CLARKE C BOYD

Former Director
55,450 -100.0%
7.62
US$422,291 		55,450 -100.0% 7.62 US$422,291
2012-07-10 2012-07-09 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.53
US$37,650 		5,000 -20.0% 7.53 US$37,650
2012-06-22 2012-06-21 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.65
US$38,250 		5,000 -20.0% 7.65 US$38,250
2012-06-19 2012-06-15 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.47
US$37,350 		5,000 -20.0% 7.47 US$37,350
2012-05-18 2012-05-16 B Purchase NB Public Equity K/S Large shareholder
50,000 +0.7%
6.67
US$333,340 		50,000 +0.7% 6.67 US$333,340
2012-05-16 2012-05-15 B Purchase CLARKE C BOYD Non-Executive Director
2,450 +3.4%
6.56
US$16,072 		2,450 +3.4% 6.56 US$16,072
2011-11-30 2011-11-29 S Sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
20,000 -50.0%
6.73
US$134,522 		20,000 -50.0% 6.73 US$134,522
2011-11-30 2011-11-29 S Sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
4,400 -9.9%
6.85
US$30,120 		4,400 -9.9% 6.85 US$30,120
2011-11-30 2011-11-28 S Sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,600 -21.9%
7.03
US$39,361 		5,600 -21.9% 7.03 US$39,361
2011-11-23 2011-11-23 B Purchase Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
1,300 +7.0%
6.78
US$8,813 		1,300 +7.0% 6.78 US$8,813
2011-11-23 2011-11-23 B Purchase Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
2,200 +13.3%
6.77
US$14,897 		2,200 +13.3% 6.77 US$14,897
2011-11-23 2011-11-23 B Purchase Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
1,500 +10.0%
6.76
US$10,143 		1,500 +10.0% 6.76 US$10,143
2011-11-23 2011-11-22 B Purchase Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
400 +2.7%
6.96
US$2,783 		400 +2.7% 6.96 US$2,783
Explore more

More insider trading research around Novelion Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America